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A B S T R A C T
Epilepsy and seizures can have a dramatic effect on the autonomic nervous system by involvement of the
central autonomic control centers. The peri-ictal changes can lead to short-term alteration of cardiac
functions in patients with seizures, and are partially hemispheric speciﬁc. Changes in heart rhythm,
conduction and even subtle signs of ischemia have been reported. Ictal asystole and the lock-step
phenomenon during seizures play an important role in the pathophysiology of SUDEP. In patients with
longlasting epilepsy and multiple seizures, there are now convincing arguments for a chronic
dysfunction of the autonomic nervous system. In this sense, heart rate variability can be considered as a
biomarker of autonomic dysfunction in epilepsy. Early recognition of these short- and long-term cardiac
effects will become useful in predicting seizures and in guiding more individualized treatment in the
near future.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
Seizure
journal homepage: www.e lsev ier .com/ locate /yse iz1. Introduction
It has been shown that epilepsy and seizures can have a
profound effect on cardiac function. Subtle cardiac rhythm changes
in the preictal and ictal period are potential biomarkers and can be
used in algorithms to anticipate and detect seizures. The
phenomenon of SUDEP is closely linked to ictal cardiac changes.* Corresponding author at: University Hospitals Leuven, Paediatric Neurology,
Herestraat 49, 3000 Leuven, Belgium. Tel.: +32 16343845; fax: +32 16343842.
E-mail address: Lieven.Lagae@uzleuven.be (L. Lagae).
1059-1311/$ – see front matter  2010 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2010.07.008In this short review, we describe the most frequent autonomic
cardiac changes seen during seizures and in epilepsy. Emphasis
will be put on the recent insights into the links between different
seizure types and cardiac changes.
In general, the autonomic nervous system is fundamental for
maintaining homeostasis in the body through regulation of heart
rate, respiration, micturition, digestion and reproduction. The
output from the autonomic nervous system is determined by a
balance of medullary reﬂexes and inﬂuences of the cerebral cortex.
The medulla integrates information from the respiratory, cardi-
ovagal and vasomotor reﬂex centers where a distinction can be
made between parasympathetic and sympathetic reﬂex centers.vier Ltd. All rights reserved.
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mediated by the vagus nerve. The vagus nerve starts in themedulla
oblongata, where it originates from two separate nuclei, the dorsal
motor nucleus (DMN) and the more ventrally located nucleus
ambiguous (NA). These two brainstem centers are thought to have
a distinct evolutionary origin. In the ‘‘polyvagal theory’’, the DMN
is considered the most primitive part of the vagus with a tonic
output on heart rate. The NA is the more recently developed or
‘‘smart vagus’’, responsible for phasic vagal output to the heart, as
reﬂected by respiratory sinus arrhythmia or RSA.1
Increase in vagal efferent activity results in decrease of heart
rate, atrio-ventricular conduction and ventricular excitability.
There is a close coupling between the respiratory centers and the
cardiovascular system. The vagal efferents receive direct input
from the respiratory centers in the brainstem. The respiratory
centers get information from aortic receptors and lung stretch
receptors. Excitation exists during expiration by stimulation of the
chemo and baroreceptors in the lungs and aorta. Inhibition is
caused by lung inﬂation through information from the lung stretch
receptors.
The sympathetic output to the heart is mediated by neurons
from the rostral ventrolateral medulla resulting in an increased
automatism of the sinus node, increase in atrio-ventricular
conduction and ventricular excitability and contractility.
Higher brain systems have a descending control on autonomic
outﬂow from the brainstem to the heart. The output of the
medullary reﬂexes is inﬂuenced by the insular cortex, orbito-
frontal cortex, cingulate, amygdala, hypothalamus and peri-
aqueductal gray matter. The insula and prefrontal cortex are
thought to represent the autonomic nervous system at the
cortical level. During fetal development, the insula is the ﬁrst
cortical center of maturation and vascularisation, with a right
sided predominance.2–4 Input from the insula can give rise to an
excitatory ‘‘pressor’’ or inhibitory ‘‘depressor’’ response at the
cardiac level.5,6 There is evidence of a hemispheric speciﬁc
organisation of this response as shown in the depth electrode
studies by Oppenheimer et al.,7 with the pressor response
lateralized to the right and depressor response to the left
hemisphere.Fig. 1. Origin of autonomic2. Acute cardiac changes and epilepsy
Changes in cardiac function in epilepsy imply an activation of
the central autonomic network. In patients with seizures, epileptic
discharges are thought to propagate to the central autonomic
network and change or disturb normal autonomic control of vital
cardiac functions. This activation of central autonomic nervous
system is thought to be responsible for the peri-ictal autonomic
cardiac symptoms observed in epilepsy patients. The importance
of these autonomic features in the pathophysiology of epilepsy and
its complications has become more clear in the last years.8–11 Due
to the hemispheric speciﬁc organisation of the central autonomic
nervous system, autonomic symptoms in epileptic seizures can
provide lateralizing and localizing information. In return, better
recognition of clinical autonomic signs in epilepsy can provide
more information on the organisation of the central autonomic
nervous system (Fig. 1).
2.1. Tachycardia
Ictal tachycardia has been reported in up to 100% of seizures.
Tachycardia can precede, coincide or follow ictal discharges.12–14
As tachycardia may also precede the clinical and EEG onset of the
seizure it is not always considered secondary to the clonic phase.
The time lag between tachycardia and seizure onset varies
between 0.7 and 49.3 s. A possible mechanism is the propagation
of epileptic discharges to the right insular cortex.7 A predominance
for tachycardia in right sided temporal seizures can be expected
and is in some13,15 but not all16,17 studies conﬁrmed, suggesting
inﬂuence of other factors to explain the tachycardia. Ictal onset
tachycardia seems more prominent in TLE as compared with
extratemporal seizures (XTLE),18,19 supporting the hypothesis that
involvement of insular cortex is a key part of ictal tachycardia. The
duration of the tachycardia is also longer in patients with mesial
temporal lobe epilepsy compared to XTLE. It is possible that
epileptic discharges propagate towards the insular cortex more
easily and for a longer duration in TLE as compared to XTLE.
Tachycardia and development of tachyarrhythmia during
seizures is one of the possible causes of sudden unexplainedsymptoms in epilepsy.
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nant ventricular tachycardia and ventricular ﬁbrillation has been
illustrated to be the cause of near SUDEP in a patient with TLE.20
2.2. Bradycardia and asystole
Bradycardia and bradyarrhythmia are much less frequent and
are seen in seizures of various origins. A severe slowing of the heart
rate leading to asystole and syncope is referred to as the ictal
bradycardia syndrome.21
actors predisposing patients to ictal bradyarrhythmia remain
difﬁcult to deﬁne. The pathophysiology of bradyarrhythmia is
probably mediated through a complex cortical network. Cortical
stimulationof the left insular cortexandamygdalaehavebeennoted
toelicit bradycardia.22,23 The left hemisphere appears tobe themore
common site of origin, again supporting the hypothesis of
hemispheric speciﬁc organisation of cortical cardiac control.24,25
An atrio-ventricular block was noted in one patient during cortical
stimulation of the left temporal basal area.26 These results suggest a
higher risk of bradyarrythmia in epileptic seizures with seizure
spreading to the left insular cortex andamygdalae. The onset zoneof
epileptic discharges in patients with ictal bradycardia is most
frequent temporal and less frontal, supporting the hypothesis of an
insular inﬂuence.
Ictal bradycardia up to ictal asystole has been reported in
patients with refractory partial seizures and could be another
important link with SUDEP.27
2.3. Conduction disorders
Conduction disorders seem to be common during seizures in
intractable epilepsy. Nei et al.28 could demonstrate the presence of
arrhythmias or conduction disorders in seizures, particularly if
these are prolonged or generalized. They include atrial ﬁbrillation,
supraventricular tachycardia and atrial and ventricular premature
depolarisation.
EKG changes, including T-wave inversion and ST-depression,
were more frequent and potentially more dangerous in patients
with generalized seizures.29
2.4. SUDEP
It is well known that people with epilepsy have an increased
risk for sudden unexpected death or SUDEP. SUDEP is deﬁned as
the sudden unexpected non-traumatic and non-drowning death of
patients with epilepsy with or without evidence of a seizure,
excluding documented status epilepticus, and in whom post-
mortem examination does not reveal a structural or toxicological
cause for death.30 Opeskin and Berkovic looked at demographics
and risk factors among epilepsy patients. Their proﬁle of patients at
risk for SUDEP are young persons with epilepsy. They are most
likely to die during sleep and seizure-related. Obstructive apnea
could be one explanation for sleep related death, but is not
supported by coroners’ ﬁndings. The position of the patient,
together with lack of supervision of recovery from the seizure is
more likely.31,32 They found no correlation with seizure frequency
or particular epilepsy or number of AEDs.33 They did not ﬁnd a
difference in duration of epilepsy between SUDEP and control
groups. However, previous studies have shown that SUDEP
patients have earlier onset, longer duration of epilepsy and more
frequent seizures. There is evidence for an increase of cardiac
autonomic stimulation in patients with SUDEP, more pronounced
in epileptic seizures during sleep,34 compatible with the demo-
graphic ﬁndings.
The exact mechanism of SUDEP remains an open question but is
probably multifactorial. An interaction between the central andperipheral autonomic nervous systemand cardiopulmonary system
is assumed. There are three well recognized main pathophysiologic
mechanisms already known to trigger SUDEP35–37:
1. cardiovascular: ictal arrhythmias including ictal asytole and the
lock-step phenomenon;
2. neurogenic: neurogenic pulmonary edema;
3. respiratory: ictal respiratory suppression, central or obstructive
apnea.
The ﬁrst possible mechanism underlying SUDEP are seizure
related cardiac arrhythmias with tachyarrhytmias, bradycardia
and ictal asystole as explained above. Tachyarrhythmias can evolve
to ventricular tachycardia and ultimately ventricular ﬁbrillation. In
bradyarrhythmias, evolution to ictal asystole is observed in
patients with focal epilepsy. Both a sudden increase of vagal tone
or the effect of post-ganglionic epileptic discharges on the heart as
described below can be considered as an explanation for the
disturbed cardiac rhythm in epileptic seizures. Schuele reported a
series of 10 patients with focal epilepsy and ictal asystole, 8 with
TLE and 2 with XTLE.38,39 The loss of consciousness was observed
during video-electroencephalographic observation and occurred
late during the clinical event. Loss of postural tonewas preceded by
8 s of asystole. In these patients activation leading to ictal asystole
is most likely mediated through an increased vagal tone. The
pattern of ictal asystole and the slowing EEG pattern of cerebral
hypoperfusion closely resembled the pattern seen in vasovagal
asystole. The underlying mechanism is most likely similar in both
conditions and assumes involvement of medullary reﬂex centers
during epileptic discharges, responsible for the increase of vagal
tone. In the two patients with XTLE asystole could have been
triggered by hypoxia due to prolonged tonic muscle contraction
and respiratory arrest, and are not due to seizure propagation to
the medullary reﬂex centers.
Another important neurophysiological phenomenon was de-
scribed by Hilz et al.40 Seizure induced activation of the central
autonomic nervous system can cause a direct effect on post-
ganglionic discharges on the heart. This results in a synchronisa-
tion of cardiac autonomic discharges with epileptogenic activity,
called the lock-step phenomenon and induces a lethal bradyar-
rythmia or asystole. Electrical stimulation of the insular cortex
results in a time-locked response on heart rhythm and can produce
different types of arrhythmia. In animal models electrical
microstimulation synchronised to the T wave of the ECG resulted
in increasing degrees of heart block and lead to escape rhythms and
ultimately asystole and dead.7 Secondary neurogenic pulmonary
edema is known as a rare life-threatening complication of central
nervous system injuries and epilepsy. Experimental studies have
postulated severe sympathetic discharge as the base of neurogenic
pulmonary edema. The cerebral sites regarded as trigger zones of
the sympathetic discharge are found in the posterior part of the
hypothalamus and in the ventral and dorsal medulla, comprising
the medial reticulated nucleus, dorsal motor vagus nucleus and
solitary tract.41 The sympathetic discharge causes systemic and
pulmonary vasoconstriction, resulting in increase in pulmonary
capillary hydrostatic pressure and shift of ﬂuid into the alveoli and
interstitium.42 A third possible mechanism in SUDEP is respiratory
suppression. Central respiratory depression can be the result of
epileptic discharges. Apnea is a rare clinical feature of seizures, but
laryngeal spasm and apnea have been reported as isolated epileptic
features or in complex partial seizures.43 The focal seizures
associated with apnea seem to originate mostly from the temporal
lobe.44 This observation together with the results of invasive EEG
monitoring in adults points to involvement of the limbic system in
seizures complicated by respiratory depression.45 Obstructive
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tonic muscle contraction during seizures. This can lead to severe
hypoxia and trigger asystole.
Besides these three important triggers in the pathophysiology of
SUDEP, the evidence for individual predisposing risk factors is
growing. In some cases, these predisposing factorsmight be genetic.
Patients with an epilepsy syndrome caused by a mutation in the
sodiumchannel gene as in generalized epilepsywith febrile seizures
plus or severe myoclonic epilepsy of infancy seem to have a higher
risk for SUDEP.46 Chronic and refractory epilepsy and treatment of
epilepsy with anti-epileptic drugs have an inﬂuence on the
autonomic balance, also predisposing patients for cardiovascular
complications. The latter will be discussed further in the text.
2.5. Syncope
The difference between syncope due to cardiac arrhythmia and
seizures in patients with established epilepsy remains clinically
challenging. In patients with epilepsy a distinction has to be made
between a cardiovascular or epileptic cause of loss of conscious-
ness and syncope. Cardiovascular autonomic balance is deter-
mined by medullary reﬂexes triggered by activation of
baroreceptors, cardiac receptors and chemoreceptors and inﬂu-
ences from the cerebral cortex, hypothalamus, amygdalae and
peri-aqueductal gray. As we mentioned earlier, patients with
epileptic seizures can develop various cardiovascular problems,
arrhythmias, ictal bradycardia and prolonged asystole caused by
epileptic discharges in higher autonomic control centers. These
cardiovascular problems can lead to ictal syncope as a result of
cerebral hypoperfusion. On the other hand, the sudden loss of tone
in patientswith ictal asystolemay be the result of ictal activation of
speciﬁc areas in the brain leading to loss of consciousness. Rapid
spread of ictal epileptic discharges with involvement of the
pontine reticular formation can lead to loss of consciousness and a
clinical syncope.5
2.6. Cardiac ischemia
As earlier mentioned, excessive autonomic stimulation may
result in cardiac arrhythmias. But repetitive autonomic stimula-
tion can also lead to structural damage to the heart. This increases
the susceptibility to cardiac arrhythmias or ischemia. Myocardial
ﬁbrosis has already been found in patients with SUDEP.47 Patients
with uncomplicated seizures do not seem to have postictal
troponin elevation, but signs of ischemia on EKG and elevated
cardiac enzymes in epileptic patients suggest secondary cardiac
damage.48,49 Alehan et al. could showpresence of elevated BNP and
CK-MB in patientswith seizures, the ﬁrst evidence of subtle cardiac
dysfunction in epilepsy patients.50
3. Chronic cardiac changes in epilepsy
3.1. Heart rate variability (HRV)
Heart ratevariabilitycanbeusedasa tool to showinformationon
the functional state of the autonomic nervous system. HRV is a
mirror of neuronal inﬂuences on the cardiac pacemaker as one of the
important functionsof theautonomicnervoussystem.ReducedHRV
has been established to be an increased risk of death in acute
myocardial infarction and in patients with diabetic neuropathy. But
various diseases are accompanied by a loss of ANS functionality and
therefore HRV can be used in health risk stratiﬁcation.51
The physiologic ﬂuctuations of the heart rate are deﬁned by
intrinsic oscillators at three different frequencies. These threemain
frequency components in HRV reﬂect the sympatho-vagal
balance.521. Respiratory sinus arrhythmia (RSA) is the most important high
frequency oscillator at 0.25 Hz. RSA is deﬁned as the high
frequency (HF) spectral component and considered as a marker
of vagal modulation. RSA is heart rate variability in synchrony
with respiration. The R–R interval is shortened during inspira-
tion and prolonged during expiration. This is a biologic
phenomenon that is thought to have a positive inﬂuence on
gas exchange by optimal ventilation/perfusion matching with
low energy expenditure.
2. In the medium frequency 0.1 Hz the Mayer waves are most
important. The rhythm corresponding toMayerwaves is deﬁned
as the low frequency (LF) component and considered as an
indicator of sympathetic activation. This rhythm originates from
the baroreceptor loop.
3. The very low frequency (VLF) component at 0.05 Hz is deﬁned
by thermoregulation, combined with humoral factors and other
slow components.
Heart rate variability was found to be lower in patients with
chronic refractory epilepsy, possibly resulting from parasympa-
thetic or vagal reduction. This can make patients more susceptible
to tachycardia and ﬁbrillation and possibly SUDEP.53,54
Impaired baroreﬂex function was observed in a study of Du¨tsch
et al. in patients with temporal lobe epilepsy.55 The impaired
function can be another sign of autonomic instability in these
epileptic patients and a contributing factor in cardiac arrhythmias.
Serious heart rate oscillations in the postictal phase were noted
in a few patients.56 Although, they occur in a minority of patients,
they could be a potential risk factor for SUDEP.
3.2. AED and HRV
Heart rate variability seems to be different in treated patients
compared to untreated. It is possible that treatment of seizures
prevents detrimental effects on autonomic cardiac control.
Hallioglu et al. found a signiﬁcant difference in children treated
with valproic acid, oxcarbazepine or phenobarbital and children
without treatment. In the treated group better HRV was found.
These results indicate that patients without anti-epileptic drug
treatment have suppressed parasympathetic activity.57 But
treatment can also have a negative effect on HRV. A suppressive
effect of carbamazepine on both parasympathetic and sympathetic
cardiac functions was found in newly diagnosed epileptic
patients.58 Lossius et al. looked at autonomic parameters after
discontinuation of monotherapy, they found an increase of both
parasympathetic and sympathetic functions, demonstrated by
spectral analysis of HRV.59
3.3. Chronic and refractory epilepsy and HRV
Patientswith longlasting andmultiple seizures seem to be prone
to chronicdysfunctionof autonomic cardiac control. Inpatientswith
newly diagnosed (median time 27months) and untreated epilepsy,
no difference was found in heart rate variability.60
Mukherjee et al.61 studied a cohort of well controlled and a
cohort of refractory patients and could show with a series of
autonomic tests that higher vasomotor tone, higher sympathetic
tone, lower parasympathetic tone and reactivity was found in the
group of refractory epilepsy patients. The observed dysautonomia
could be a predisposing factor to SUDEP. Chroni et al.62 could
demonstrate altered cardiovagal control in patients with chronic
epilepsy. They used simple neurophysiologic tests of the auto-
nomic nervous system, Valsalva, Tilt-test, RR interval in normal
and deep breathing and sural nerve conductance to show a chronic
effect of epilepsy on the autonomous nervous system. Sathya-
prabha et al.63 used heart rate and blood pressuremeasurements in
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was found in 56.3% of the patients with chronic refractory epilepsy,
compared to a control group. In their study the dysfunction of the
autonomic system was more severe if the epilepsy was longer
lasting.
Ansakorpi et al.64,65 looked at refractory TLE patients to
demonstrate interictal autonomic dysfunction in response to
certain stimuli. He used newer analysis methods to demonstrate
altered complexity of heart rate in refractory epilepsy patients.
Ronkainen et al.66 found loss of HRV and suppressed circadian
dynamics in TLE, as well in controlled as in refractory patients.
In children with refractory epilepsy, the same arguments for a
chronic autonomic dysfunction are found. Heart rate abnormalities
were noted in children and adolescents with complex partial
seizures. The abnormalities were much more frequent compared
to adults and occurred in 98% of the complex partial seizures. Heart
rate variability also seems to be lower in children with chronic
refractory epilepsy, possibly resulting from parasympathetic or
vagal reduction. This can make patients more susceptible to
tachycardia and ﬁbrillation54 (Harnod).
3.4. Vagal nerve stimulation (VNS) and HRV
The vagal nerve consists for 80% out of afferents and 20% of
efferents. Vagal efferents originate in the nucleus ambiguus and
DMNof the vagus. Cell bodies in the nucleus ambiguus send special
visceral efferent ﬁbers to the striated muscle ﬁbers of palate,
pharynx, larynx and esophagus. Cell bodies in the DMN send
general efferents to the heart, lungs and gastro-intestinal tract.
Afferent ﬁbers originate in the end organs: heart, lungs and gastro-
intestinal tract. These cells project axons to the nucleus tractus
solitaries (NTS), which then project to hypothalamus, amygdale,
dorsal raphe and thalamus. Vagal nerve stimulation produces
evoked potentials recorded from the cerebral cortex, the hippo-
campus, the thalamus, and the cerebellum.Most of the cardiovagal
ﬁbers run through the right vagus nerve, so stimulation of the left
vagus in the treatment of epilepsy is preferred to avoid potential
detrimental effects on heart rhythm.67 These structures in turn
synapse throughout the cerebral cortex and seem to have an
overall inhibitory effect. This was supported by the study of Ben-
Menachem et al.68 who showed an increase of GABA in the CSF in
patients with VNS and a decrease of the excitatory aspartate.
For a long time, stimulation of the vagal nerve with VNS was
thought to have no effect on cardiac action. In contrast, Frei and
Osorio69 showed that left vagal nerve stimulation has complex
effects on instantaneous heart rate and heart rate variability with
large interindividual variability. They found different cardiac
chronotropic effects, either bradycardia or tachycardia, immedi-
ately followed by bradycardia during stimulation. HRV was found
to be increased or decreased.
The recent work of Stemper and Devinsky70 showed that VNS
inﬂuences both sympathetic and parasympathetic cardiac regula-
tions. The variability of the observed responses in patients treated
with VNS illustrates the interplay of divers afferent information
and central inﬂuences.
4. Conclusion
There is growing evidence for the importance of the involve-
ment of the central autonomic nervous system in epilepsy patients.
Short-term alteration of cardiac functions in patients with
seizures is caused by involvement of the central autonomic control
centers in seizure activity. Due to a hemispheric speciﬁc
localization of these control centers, the effect can give information
on lateralisation of the seizure. In return, autonomic symptoms in
seizure semeiology can give information on the localisation andlateralisation of important autonomic centers in the central
nervous system as shown in the ﬁgure. Acute changes in cardiac
function during seizures include tachycardia, bradycardia up to
ictal asystole and more subtle conduction disorders. The patho-
physiology of syncope in patients with epilepsy remains difﬁcult.
Loss of consciousness can be due to cardiovascular complications
or involvement of the pontine reticular formation in seizure
propagation. Repetitive autonomic stimulation can lead to
structural damage of the heart. Cardiac ischemia as well as
myocardial ﬁbrosis is already demonstrated in epilepsy patients.
The mechanism of SUDEP is multifactorial. We can identify three
different pathophysiologic triggers: acute cardiovascular changes
during seizures, tachyarrhythmias, bradyarrhythmias and ictal
asystole, neurogenic pulmonary edema and respiratory complica-
tions with central and obstructive apnea. Besides these triggers,
chronic epilepsy, drugs and genetics seem to be important
predisposing factors in patients with epilepsy.
In patients with longlasting epilepsy and multiple seizures,
there are arguments for a chronic dysfunction of the autonomic
nervous system. Heart rate variability is one of themarkers used to
show information on the functional state of the autonomic nervous
system and is impaired in patients with longlasting epilepsy and
refractory seizures. Treatment of epilepsy with AED, not only VNS
can improve but also suppress heart rate variability. Early
recognition and possible prevention of these short- and long-
term effects can prove to be of vital importance in the future.
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